Thèses sur le sujet « Medical policy – Europe »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 17 meilleures thèses pour votre recherche sur le sujet « Medical policy – Europe ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les thèses sur diverses disciplines et organisez correctement votre bibliographie.
Radin, Dagmar. « Too Ill to Find the Cure ? - Health Care Sector Success in the New Democracies of Central and Eastern Europe ». Thesis, University of North Texas, 2006. https://digital.library.unt.edu/ark:/67531/metadc5348/.
Texte intégralKostera, Thomas. « When Europa meets Bismarck : cross-border healthcare and usages of Europe in the Austrian healthcare system ». Doctoral thesis, Universite Libre de Bruxelles, 2014. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209268.
Texte intégralDoctorat en Sciences politiques et sociales
info:eu-repo/semantics/nonPublished
Palmedo, P. Christopher. « Equality, Trust and Universalism in Europe, Canada and the United States : Implications for Health Care Policy ». PDXScholar, 2014. https://pdxscholar.library.pdx.edu/open_access_etds/1929.
Texte intégralBeckhoven, Ellen van. « Decline and regeneration : policy responses to processes of change in post-WWII urban neighbourhoods / ». Utrecht : Koninklijk Nederlands Aardrijkskundig Genootschap : Universiteit Utrecht, Faculteit Geowetenschappen, 2006. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=016413115&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA.
Texte intégralNickel, Christiane. « Insider und Outsider bei der Osterweiterung der europäischen Währungsunion / ». Frankfurt : Lang, 2002. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=009495992&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA.
Texte intégralIosifides, Petros. « Media concentration policy in the European Union and the public interest ». Thesis, University of Westminster, 1996. https://westminsterresearch.westminster.ac.uk/item/948x9/media-concentration-policy-in-the-european-union-and-the-public-interest.
Texte intégralStewart, Emma J. « The European Union and conflict prevention : policy evolution and outcome / ». Münster : LIT, 2006. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=014648755&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA.
Texte intégralCheiladaki, Maria. « Supranational institutions, path dependence and EU policy development : the cases of student and patient mobility ». Thesis, University of Sussex, 2011. http://sro.sussex.ac.uk/id/eprint/7582/.
Texte intégralCostache, Andreea Madalina. « De-regulation of european media policy (2000-2014) The debate on media governance and media pluralism in the EU ». Doctoral thesis, Universitat Autònoma de Barcelona, 2014. http://hdl.handle.net/10803/284884.
Texte intégralThis PhD dissertation analyses the case of the regulation of media pluralism at the European Union’s institutions level. The main objective is to examine if there is an evolution on the EU media policy change from strict-government regulation to a soft-governance approach regarding the protection of pluralism from 2000 to 2014. In the first part the theoretical framework is developed, based on two theoretical concepts: media pluralism and soft-governance. In this regard, this study argues that media pluralism can be better protected if the statutory governance at national level of Member States is complemented with soft-regulatory measures at the EU level, considering the circumstances of the European Commission limitation of competences. In the second part are analyzed the media policy actions at the EU level. A distinction is made here between the policy actions and initiatives for the protection of media pluralism advanced by the EU institutions like European Parliament, the Council of Europe, civil society organizations and the ones of the European Commission. The hard-regulatory initiatives, strategies and arguments and soft-regulatory ones towards the protection of media pluralism, coming from all the media policy actors, are discussed. In this way, it can be assessed if the European Commission is distancing further more from the subject of media pluralism or is bridging the gap towards the initiatives of the Member States to complement these initiatives with soft-regulatory initiatives at the EU level.
Schreiner, Patrick. « Staat und Sprache in Europa : nationalstaatliche Einsprachigkeit und die Mehrsprachenpolitik der Europäischen Union / ». Frankfurt am Main [u.a.] : Lang, 2006. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=014628095&line_number=0004&func_code=DB_RECORDS&service_type=MEDIA.
Texte intégralAdes, Moraes Felipe. « Evaluation of the disparities in trastuzumab approval, reimbursement and uptake across the 27 European Union Member States (EU-27) ». Doctoral thesis, Universite Libre de Bruxelles, 2015. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209132.
Texte intégralcomposed by 27 member states (EU-27). The EU implemented several standardizations in laws,
justice and home affairs and shares the consensus that health care should be regulated by the
state. A high level of human protection should be ensured in all its member states. European
health systems are funded and managed by each national government and for historical
reasons health policy and health expenditure are not homogeneous.
Whereas cancer incidence is dependent on factors such as population age, life-style and
genetic predisposition, cancer mortality in general is dependent on the efficacy of health
systems in providing cancer prevention, efficient screening methods and treatments.
Around 20% of the breast cancers show amplification/overexpression of HER2 that is
associated with a more aggressive disease and worse clinical outcome. By targeting the HER2
receptor trastuzumab has significantly improved overall survival and changed the natural
course of this disease.
Objectives: This study aims to evaluate (1) the association of health expenditure with
breast cancer outcome, (2) to explore to which degree the differences in breast cancer survival
are related to the speed of uptake of trastuzumab and its determinants and (3) to evaluate the
real usage of trastuzumab and its relation to breast cancer survival in the EU.
Results: Breast cancer survival was found strongly correlated with health expenditure. A
clear cutoff divides Western and Eastern Europe in that regard, with western countries showing
higher health expenditure and higher breast cancer survival than Eastern Europe. Trastuzumab
reimbursement was faster in Western European countries, a factor associated with higher
health expenditure and better health policy performance. Trastuzumab uptake is increasing all
over Europe in the last 12 years, however it is still being under used in Eastern countries while
in Western Europe the uptake is sufficient to treat virtually all patients in need of the drug.
Conclusion: Important discrepancies in breast cancer survival exist in the EU. Western
Europe has higher breast cancer survival and higher health expenditure than Eastern Europe.
This can be partially explained by the faster approval and increased uptake of trastuzumab in
Western countries. Higher health expenditure and better health policy performance were
factors linked to faster reimbursement and uptake of trastuzumab.
Doctorat en sciences médicales
info:eu-repo/semantics/nonPublished
Pelletier, Christine. « Application des techniques d'aide à la décision à la planification sanitaire régionale ». Phd thesis, Université Joseph Fourier (Grenoble), 1999. http://tel.archives-ouvertes.fr/tel-00004845.
Texte intégralGRANGE, Aline. « Au-delà des traités communautaires ? : l'européanisation des politiques sanitaires et sociales des drogues : diffusion et apprentissage autour de la notion de réduction des risques en France, en Italie et aux Pays-Bas ». Doctoral thesis, 2004. http://hdl.handle.net/1814/5128.
Texte intégralExamining board: Prof. Martin Rhodes, IUE (directeur de thèse) ; Prof. Adrienne Héritier, IUE/RSCAS ; Prof. Henri Bergeron, CNRS (Paris), Observatoire européen des drogues et des toxicomanies (Lisbonne) ; Prof. Renaud Dorandeu, Institut d'Etudes Politiques, Univ. R. Schuman (Strasbourg)
PDF of thesis uploaded from the Library digitised archive of EUI PhD theses completed between 2013 and 2017
SMISMANS, Stijn. « Functional participation in European occupational health and safety policy : democratic nightmare or additional source of legitimacy ? » Doctoral thesis, 2002. http://hdl.handle.net/1814/4787.
Texte intégralExamining Board: Prof. G. de Búrca (EUI Law Department), co-supervisor ; Prof. R. Dehousse (Institut d'Etudes Politiques, Paris/ former EUI Law Department), supervisor ; Judge K. Lenaerts (Court of First Instance/ and Katholieke Universiteit Leuven) ; Prof. P.C. Schmitter (EUI Department of Political and Social Sciences)
PDF of thesis uploaded from the Library digitised archive of EUI PhD theses completed between 2013 and 2017
STAVROULAKI, Theodosia. « Integrating healthcare quality concerns into a competition law analysis : mission impossible ? » Doctoral thesis, 2017. http://hdl.handle.net/1814/49704.
Texte intégralExamining Board: Professor Giorgio Monti, European University Institute (Supervisor); Professor Hans-Wolfgang Micklitz, European University Institute; Dr. Okeoghene Odudu, University of Cambridge; Professor Daniel Sokol, Levin College of Law, University of Florida
Healthcare markets have started being created in Europe. Indeed, some European countries, such as the UK and the Netherlands, have started adopting the choice and competition model for healthcare delivery. Taking as a starting point that as health systems in Europe move towards market driven healthcare delivery, the application of competition law in these systems will increase, the goal of this doctoral thesis is (a) to identify some of the competition problems that may be raised in light of the reality that especially in hospital and medical markets the pursuit of competition and the pursuit of essential dimensions of healthcare quality may inevitably clash (b) to demonstrate that competition authorities would be unable to address some of these competition problems if they did not pose and address a fundamental question first: how should we define and assess quality in healthcare? How should we take healthcare quality into account in the context of a competition analysis? In delving into these questions, this doctoral thesis explores how the notion of healthcare quality is defined from antitrust, health policy and medicine perspectives and identifies three different models under which competition authorities may actually assess how a specific anticompetitive agreement or hospital merger may impact on healthcare quality. These are: (a) the US market approach under which competition authorities may define quality in healthcare strictly as choice, variety, competition and innovation (b) the European approach under which competition authorities may extend the notion of consumer welfare in healthcare so that it encompasses not only the notions of efficiency, choice and innovation, but also the wider objectives and values European health systems in fact pursue (c) the UK model under which competition authorities may cooperate with health authorities when they assess the impact of a specific transaction on healthcare quality. The thesis identifies the main merits and shortcomings of these models and emphasizes that what is crucial for the adoption of a holistic approach to healthcare quality is not only the model under which healthcare quality is actually integrated into a competition analysis but also competition authorities’ commitment to protect all dimensions of this notion.
Chapter IV ‘Integrating healthcare quality concerns into the US hospital merger cases : a mission impossible’ of the PhD thesis draws upon an earlier version published as an article 'Integrating healthcare quality concerns into the US hospital merger cases : a mission impossible' (2016) in the journal 'World competition'
Leutgert, Brooke. « Disentangling the roots of public support for European integration : exploring the effect of EU policy / ». 2007. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=018700018&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA.
Texte intégralOLESEN, Jeppe Dørup. « Adapting the welfare state : privatisation in health care in Denmark, England and Sweden ». Doctoral thesis, 2010. http://hdl.handle.net/1814/14504.
Texte intégralExamining Board: Jens Blom-Hansen (Aarhus Univ), Pepper Culpepper (EUI), Bo Rothstein (Univ. Gothenborg), Sven Steinmo (EUI) (Supervisor)
First made available online on 8 April 2019
This dissertation deals with the following question: In the past decades some of the countries most dedicated to the universal public welfare state have privatised many of their welfare service provisions. Why is this so? The dissertation takes a close look at privatisation policies in health care in Denmark, Sweden and England in order to figure out how and why the private health care sector has expanded rapidly in recent years. Health care services in Denmark, Sweden and England provide good examples of welfare state service privatisation because these three countries have spent decades building up universal public health care systems that offer free and equal access to all citizens - and these programmes are very popular. In this dissertation I find that the most common explanations for welfare state reform fail to explain these changes: Privatisation policies are not the result of partisan politics, instead they are supported by Social Democratic / Labour parties and in some cases the unions as well. Privatisation is not the result of pressures for fiscal retrenchment; in fact, public health care funding has increased in all three countries over the past decade. Neither is privatisation the straight forward result of new right wing ideas. Certainly, new ideas play a role in this change, but it is difficult to sustain the argument that ideas alone have been the cause of privatisation in these three health care systems. Finally, it has been debated whether privatisation is the result of pressure from EU legislation. This explanation does not hold either for the basic reason of timing. The policies leading to privatisation in Denmark, England and Sweden were all implemented before the European debate over health care services started. Instead, I suggest that privatisation in health care in Denmark, Sweden and England can best be understood as the product of policy makers puzzling over important policy problems (Heclo, 1972). I call this an adaptive process. In this analysis I show that privatisation is the result of several interconnected attempts to adapt health care systems to a changing context. By taking a long historical view of the changes in health care systems, it becomes evident that the changes towards privatisation do not occur overnight or as a result of a ‘punctuated equilibrium’. Rather, the increasing privatisation in health care is the accumulated effect of several small step policy changes, which, over time, result in rising levels of privatisation. Some scholars have suggested that neo-liberal policies, such as privatisation of service provision, will ultimately lead to the end of the welfare state. In this study, I come to a different conclusion. Rather than undermine the welfare state, privatisation in health care may help the welfare state survive. Privatisation can be seen as a way of adapting welfare state services to a changing political context.